NCT04964089Phase 3Completed

A Study to Evaluate the Efficacy and Safety of Intravitreal KSI-301 Compared With Intravitreal Aflibercept in Participants With Neovascular (Wet) Age-related Macular Degeneration (wAMD)

Study sponsor: Kodiak Sciences Inc · KOD

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2023-03-28Actual
Enrollment · participants557Actual
Source updated2024-07-03Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview